Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilfried Roth

Showing results (91-100 of 196) with videos related to

Pageof 20
Sort By:
Science Advances|March 18, 2022
ARAF suppresses ERBB3 expression and metastasis in a subset of lung cancersJuliane Mooz, Kristina Riegel, Hari Ps, et al.
British Journal of Cancer|November 5, 2016
No association of CpG island methylator phenotype and colorectal cancer survival: population-based studyMin Jia, Lina Jansen, Viola Walter, et al.
Cells|November 27, 2021
Knockout of the KH-Type Splicing Regulatory Protein Drives Glomerulonephritis in MRL-Fas<sup>lpr</sup> MiceLisa Schmidtke, Myriam Meineck, Sabrina Saurin, et al.
Cell and Tissue Research|May 13, 2018
Widespread expression of perilipin 5 in normal human tissues and in diseases is restricted to distinct lipid droplet subpopulationsMerita Hashani, Hagen Roland Witzel, Lena Maria Pawella, et al.
Scientific Reports|August 19, 2021
Comparative analysis of nuclear and mitochondrial DNA from tissue and liquid biopsies of colorectal cancer patientsAnna Haupts, Anne Vogel, Sebastian Foersch, et al.
Oncotarget|November 29, 2016
MET expression and copy number status in clear-cell renal cell carcinoma: prognostic value and potential predictive markerStephan Macher-Goeppinger, Martina Keith, Volker Endris, et al.
Molecules (Basel, Switzerland)|May 14, 2025
Drug Repurposing to Inhibit Oncostatin M in Crohn's DiseaseFaranak Bahramimehr, Axel Guthart, Stefanie Kurz, et al.
Frontiers in Oncology|May 29, 2019
PD-L1 Expression and Immune Cell Infiltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative ActivityMartina Ferrata, Arno Schad, Stefanie Zimmer, et al.
European Urology|May 2, 2020
Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological SlidesAnn-Christin Woerl, Markus Eckstein, Josephine Geiger, et al.
Neoplasia (New York, N.Y.)|September 25, 2008
Decoy receptor 3 is a prognostic factor in renal cell cancerStephan Macher-Goeppinger, Sebastian Aulmann, Nina Wagener, et al.
Pageof 20

Showing results (91-100 of 196) with videos related to

Sort By:
Pageof 20
Science Advances|March 18, 2022
ARAF suppresses ERBB3 expression and metastasis in a subset of lung cancersJuliane Mooz, Kristina Riegel, Hari Ps, et al.
British Journal of Cancer|November 5, 2016
No association of CpG island methylator phenotype and colorectal cancer survival: population-based studyMin Jia, Lina Jansen, Viola Walter, et al.
Cells|November 27, 2021
Knockout of the KH-Type Splicing Regulatory Protein Drives Glomerulonephritis in MRL-Fas<sup>lpr</sup> MiceLisa Schmidtke, Myriam Meineck, Sabrina Saurin, et al.
Cell and Tissue Research|May 13, 2018
Widespread expression of perilipin 5 in normal human tissues and in diseases is restricted to distinct lipid droplet subpopulationsMerita Hashani, Hagen Roland Witzel, Lena Maria Pawella, et al.
Scientific Reports|August 19, 2021
Comparative analysis of nuclear and mitochondrial DNA from tissue and liquid biopsies of colorectal cancer patientsAnna Haupts, Anne Vogel, Sebastian Foersch, et al.
Oncotarget|November 29, 2016
MET expression and copy number status in clear-cell renal cell carcinoma: prognostic value and potential predictive markerStephan Macher-Goeppinger, Martina Keith, Volker Endris, et al.
Molecules (Basel, Switzerland)|May 14, 2025
Drug Repurposing to Inhibit Oncostatin M in Crohn's DiseaseFaranak Bahramimehr, Axel Guthart, Stefanie Kurz, et al.
Frontiers in Oncology|May 29, 2019
PD-L1 Expression and Immune Cell Infiltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative ActivityMartina Ferrata, Arno Schad, Stefanie Zimmer, et al.
European Urology|May 2, 2020
Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological SlidesAnn-Christin Woerl, Markus Eckstein, Josephine Geiger, et al.
Neoplasia (New York, N.Y.)|September 25, 2008
Decoy receptor 3 is a prognostic factor in renal cell cancerStephan Macher-Goeppinger, Sebastian Aulmann, Nina Wagener, et al.
Pageof 20